[eBook] Therapeutic proteins: bioprocessing methods for mAb generation

Supplied by Eppendorf on Wednesday, 20 November, 2024

Antibodies have long been vital in research and diagnostics, but their lab utility was limited by their polyclonal nature. To stay competitive, production must become more efficient, cost-effective, and higher in quality.

Download this eBook to learn about:

·key methods for mAb validation and development

·the potential of P. pastoris as a next-gen mAb production platform

·strategies for ensuring reliable, reproducible mAb research and drug development.

DOWNLOAD

39 Pages PDF

Related White Papers

Leveraging Adeno-Associated Viruses (AAVs) in therapeutic approaches for monogenic neurological diseases

Learn about key strategies and innovations in this...

Next-gen weight-data integration: cloud, IT and control system connectivity

Discover the latest innovations that can...

Streamlined set-up and access to multiple read-out options with PROTAC assays

Latest PROTAC advances raise the bar for oncology...

Content from other channels on our network

Solving the hospital kitchen hygiene challenge

In Conversation with Australia's Chief Medical Officer, Professor Michael Kidd AO

Group Captain Kath Stein FACN GAICD becomes ACN president

ACSQHC unveils first new brand and 2025–30 strategic plan

Queensland-wide senior medical officers audit underway

New Report Reveals Next-Gen Tech Driving Major Growth in Australian Food Processing

Energy-efficient plate freezing: No longer just for the big players

Energy Management in Manufacturing: One System Doesn't Fit All

Aussie SMEs leaving billions of dollars in grants on the table

New Zealand distillery Scapegrace set to ramp up in Australia

No More Blockages for Western Sydney Meat Works after Gorman-Rupp Pump Upgrade

Taking the electronic pulse of the circular economy

Radio station set to reduce emissions by 25%

New firming tender to protect NSW's energy security

Council provides rebates to improve energy efficiency